According to the World Health Organization, there were 39.9 million people living with HIV worldwide by the end of 2023.

Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

Richard says it took two days for a qualified interpreter to arrive and explain he had been given the all-clear. "If an ...

VIDEO | Jamtara: On the HIV blood transfusion row involving thalassemia-infected children, Jharkhand Health Minister Irfan ...

A man with HIV accused of raping children was arrested by the Memphis Safe Task Force Thursday, the U.S. Marshals Service ...

Gilead beats estimates, raises 2025 guidance, driven by strong HIV and liver drug sales and multiple launches planned for ...

GLAAD--the world's largest lesbian, gay, bisexual, transgender, and queer (LGBTQ) media advocacy organization––invited Snoop ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...

Gilead is actively looking for late-stage and de-risked assets for potential deals across various therapeutic spaces, ...

For the last several quarters, Gilead Sciences’ earnings calls have been colored by anticipation for the launch of the California drugmaker's long-acting HIV pre-exposure prophylaxis (PrEP) option. | ...

Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...